Active, not recruitingPhase 3NCT06516042

Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia

Studying Malaria

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
PATH
Principal Investigator
Adam Bennett, PhD
PATH
Intervention
Dihydroartemisinin-piperaquine(drug)
Enrollment
10350 target
Eligibility
14 years · All sexes
Timeline
20242025

Study locations (1)

Collaborators

Federal Minstry of Health of Ethiopia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06516042 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria

← Back to all trials